What is a Failure Mode and Effects Analysis (FMEA) and how would you apply it to a new medication administration workflow?

• A. FMEA is a proactive risk assessment tool that scores failure modes by severity, occurrence, and detectability to prioritize fixes. Apply to medication workflow by mapping steps, identifying potential failures (look-alike/sound-alike meds, wrong dose), scoring, and implementing high-priority interventions.
• B. RCA is a post-incident blame process.
• C. A financial risk assessment for procurement.
• D. A retrospective chart review.

Answer: (A)

Failure Mode and Effects Analysis is a proactive risk assessment method that helps teams anticipate where a process could fail and estimate how serious the consequences would be, how likely the failure is, and how easily it could be detected before harm occurs. By scoring these factors for each potential failure mode, the team creates a prioritized list of risks to address and guides where to focus improvement efforts.

To apply this to a new medication administration workflow, gather a multidisciplinary team and map the entire process from order entry through administration to monitoring. Identify potential failure modes at each step—such as look-alike/sound-alike medications, incorrect dosing, wrong patient, transcription errors, interruptions during preparation, or incorrect route. For each identified failure mode, assess severity (how bad the outcome would be), occurrence (how often it might happen), and detectability (how likely you are to catch it before it reaches the patient). Use these assessments to calculate a risk priority and target high-priority risks for intervention. Implement changes such as bar-code verification, unit-dose packaging, tall-man lettering, double-checks or independent verification for high-risk meds, smart pumps, clear labeling, and strategies to minimize interruptions. After implementing changes, re-evaluate the process to confirm risk has been reduced.

The other approaches described focus on reacting to problems after they occur or on different types of risk analyses, rather than proactively identifying and mitigating potential failure points in a medication administration workflow.